⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DHR News
Danaher Corporation
High Content Screening Market 2026-2034: Size, Share, Trends, and Forecast by Product, Application, End-User, and Region | AI-Led Drug Discovery Drives 6.85% CAGR to $2.8 Billion
globenewswire.com
BDX
BIO
DHR
GEHC
TTEC
Global Microfluidics Market by Product Type, Application, End User, and Region, 2026-2036 | $48.04 Billion Opportunity Driven by Point-of-Care Diagnostics and Automation
globenewswire.com
A
TMO
QGEN
ILMN
LAB
DHR
ABT
BIO
GCC Mass Spectrometry Market Size, Share, Trends, and Growth Forecast (2021 - 2034) | Precision Medicine and Regulatory Demand Propel 7.9% CAGR to US$395.58 Million
globenewswire.com
BRKR
DHR
TMO
WTRG
RVTY
High-throughput Screening Market Size, Share, Trends, and Growth Forecasts, 2026-2031 | AI Automation and Asia-Pacific Growth Drive a USD 45.07 Billion Opportunity
globenewswire.com
TMO
DHR
AGNC
MRK
GEHC
BIO
CRL
Label-Free Array Systems Market Share, Trends, and Growth Forecasts, 2026-2031 Report Released; Market Projected to Reach USD 874.12 Million by 2031
globenewswire.com
DHR
BRKR
GLW
TMO
GEHC
Therapeutic Drug Monitoring Market Size, Share, Industry Trends, and Growth Forecasts, 2026-2031 | Precision Dosing and Wearables Drive 9.03% CAGR Toward USD 2.29 Billion
globenewswire.com
ABT
TMO
DHR
BIO
WTS
BRKR
LH
IVD Quality Control Market to Reach US$ 2.2 Bn by 2031, Growing at 5.3% CAGR as Labs Shift to Automated QC Workflows: New Report by Wissen Research
prnewswire.com
ABT
DHR
BIO
TMO
QDEL
Europe DNA Plasmid Manufacturing Market Size, Share, Trends, and Forecast, 2021 - 2031 | Gene Therapy and CDMO Demand Fuel 21.2% CAGR, Reaching US$592.6 Million
globenewswire.com
DHR
TMO
Global Oligonucleotide Synthesis Reagents Market Size, Share, and Forecast, 2026-2033 | Therapeutics Demand Fuels 11.9% CAGR and USD 1.75 Billion Opportunity
globenewswire.com
TMO
DHR
A
TWST
RNA Extraction and Purification Market Size, Share, Trends, and Forecast, 2026-2033 | Market to Reach USD 5.10 Billion at 9.4% CAGR as RNA Therapeutics and Diagnostics Expand
globenewswire.com
A
BIO
DHR
ILMN